SINTX Raises $3.8M Through Warrant Exercise to Strengthen Working Capital

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,099,431 shares of common stock of the Company originally issued in February 2025, having an exercise price of $3.32 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-3 (No. 333-285932).

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash and the payment of additional $0.125 per new unregistered warrant (additional $206,143.31 in the aggregate, which is included in the gross proceeds to the Company), the Company will issue to the holders of the warrants new unregistered warrants to purchase up to 1,649,147 shares of common stock. The new warrants will have an exercise price of $4.79 per share, will be exercisable immediately upon issuance and will expire five and one-half years after the date of issuance.

The gross proceeds to the Company from the exercise of the warrants and issuance of the new warrants are expected to be approximately $3.8 million, prior to deducting placement agent fees and estimated offering expenses.

The offering is expected to close on or about September 9, 2025, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital purposes.